Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030
Liver International · 2024
DOI: 10.1111/liv.15883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Guoqing Ouyang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Liuzhou People's Hospital, Liuzhou, Guangxi, China. Hauptthemen laut MEDLINE: Hepatitis E, Global Burden of Disease, Disability-Adjusted Life Years, Global Health. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Liuzhou Science and technology planning project(2021CBC0101).
Abstract (Originalsprache)
Background and Aims Acute hepatitis E (AHE) is still a public health issue worldwide. Here, we report the global burden of AHE in 204 countries and territories from 1990 to 2019 by age, sex and socio‐demographic index (SDI), and predict the future trends to 2030.
Methods
Data on AHE were collected from the Global Burden of Diseases, Injuries and Risk Factors Study 2019. The average annual percentage change (AAPC) and joinpoint analysis were used to determine the burden trend.
Results
In 2019, there were 19.47 million (95% UI, 16.04 to 23.37 million) incident cases of AHE globally, with a 19% increase since 1990. Age‐standardized rate (ASR) of disability‐adjusted life years (DALYs), prevalent and incident cases declined from 1990 to 2019. In 2019, the ASR of incidence, prevalence and DALYs due to HEV infection were highest in the same regions of South Asia for both sexes. Southern Sub‐Saharan Africa presented the highest increases in the ASR for incidence of HEV infection in both males (AAPC = .25) and females (AAPC = .24) from 1990 to 2019. Incident cases are higher in males than females before 55–59 years old. The SDI values were negatively correlated with the age‐standardized DALYs. Between 2019 and 2030, the ASR for incidence and prevalence of HEV for both sexes showed an increasing trend.
Conclusions
Although the overall ASR of AHE decreased, the burden of AHE remains an underappreciated problem for society. The findings may provide useful information for policymakers to develop appropriate strategies aimed at reducing the burden of AHE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Liuzhou People's Hospital, Liuzhou, Guangxi, China.
- Liuzhou Hepatobiliary and Pancreatic Diseases Precision Diagnosis Research Center of Engineering Technology, Liuzhou, Guangxi, China.
- Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- Department General Surgery, Luzhai People's Hospital, Liuzhou, Guangxi, China.
- Department of Hepatobiliary Surgery, Changsha Hospital of Traditional Chinese Medicine, Changsha, Hunan, China.
ORCID-Profile: Guoqing Ouyang, Zhipeng Liu
Förderung
- Liuzhou Science and technology planning project(2021CBC0101)
Zitieren
APA
Ouyang, G., Pan, G., Li, Q., Li, S., Liu, T., Yi, X., & Liu, Z. (2024). Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030. Liver International. https://doi.org/10.1111/liv.15883
Vancouver
Ouyang G, Pan G, Li Q, Li S, Liu T, Yi X, et al. Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030. Liver International. 2024. doi:10.1111/liv.15883
BibTeX
@article{Ouyang2024,
author = {Ouyang, Guoqing and Pan, Guangdong and Li, Qiuyun and Li, Shuang and Liu, Tao and Yi, Xiaolei and Liu, Zhipeng},
title = {Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15883}
}
EUVIMED